News

Xylogenics Ethanol Bioengineering Firm Names New Board Appointments

INDIANAPOLIS (March 18, 2009)—Indianapolis-based Xylogenics ethanol bioengineering firm recently named two officers to its board of directors. Butch Mercer, CEO of BioMark, was named chairman and Nick Mathioudakis, partner at Baker & Daniels, joined the board to serve as its secretary and will also serve as a legal and business advisor to Xylogenics.

Mercer is founder and CEO of BioMark, an executive management and business consulting firm for the biotechnology field and related industries. He has more than 30 years of executive and strategic management experience and is a globally recognized speaker in biotechnology and related fields. Mercer recently led Dow AgroSciences to successfully develop and obtain the world’s first registration for a plant-made vaccine.

Mathioudakis is a partner with the Baker & Daniels law firm. Specializing in business and technology, he has experience building technology companies and has founded software and life sciences companies. He is a frequent speaker and panelist on issues relating to raising capital, business development and entrepreneurship.

“Butch and Nick both make excellent additions to the Xylogenics board of directors,” said Mike Neibler, CEO of Xylogenics. “Their extensive business management experience and proven track records in the biotechnology and information technology industries will truly be assets to the company and will help advance Xylogenics in the development of its exclusive cellulose ethanol technology.”

Neibler notes: “Xylogenics has met with a lot of excitement surrounding its proprietary cellulosic ethanol technology. The technology is unique in that it will allow for the addition of biomass ethanol production along with corn-based ethanol production, and can utilize the existing ethanol manufacturing facilities and infrastructure. We are well-positioned to help Indiana ethanol producers improve their corn ethanol yields and at the same time help transition to cellulosic ethanol.”

Xylogenics is a bioengineering firm based in Indianapolis that develops genetically modified yeast strains to increase the production efficiency of ethanol from biomass. These proprietary yeast strains can potentially boost fermentation yields by 30 to 50 percent in existing cellulosic ethanol production facilities. Xylogenics patent pending technology increases the amount of cellulosic material converted to ethanol resulting from its proprietary bioengineered yeast strains optimizing yield efficiencies. For more information, visit www.xylogenicsinc.com.